Therapeutic plasma exchange in pediatric intensive care: Indications, results and complications
- PMID: 31922326
- DOI: 10.1111/1744-9987.13474
Therapeutic plasma exchange in pediatric intensive care: Indications, results and complications
Abstract
Therapeutic plasma exchange (TPE) is an effective treatment method in selective indications. Secondary to access and technical features, it is more difficult to apply in pediatric population than adults. The aim of this study is investigate safety, clinical indications, and results of this method in critically ill pediatric patients who need TPE treatment. All of the TPE procedures performed in a pediatric intensive care unit providing tertiary care during 4 years (2015-2019) were evaluated retrospectively. TPE procedures (635) were performed for 135 patients. Median age was 34 months (10-108). Ninety-seven patients had mechanical ventilation support. Sepsis with multiple organ failure was the most frequent indication and accounted for 44.4% (n = 60) of the indications followed by hematological and neurological diseases (19.2% and 9.6% respectively). TPE was performed alone in 469 cases (73.9%), in combination with continuous renal replacement therapy in 154 cases (24.2%), and additional to extracorporeal membrane oxygenation in 12 cases (1.9%). Hematological disease and sepsis subgroups had the highest intubation rate, mechanical ventilation period, PRISM score, organ failure count, and mortality. Fresh frozen plasma (FFP) was the most frequently used replacement fluid in 90.4% of the procedures. The most frequent anticoagulant used in TPE was acid citrate dextrose solution (79.3%). Procedural complications were detected in 104 cases (16.3%) and occurred during TPE sessions. Overall survival rate was 78.5%. We found that the non-survivor group had significantly higher rates of organ failures (P = 0.0001), higher PRISM scores on admission (P = 0.0001), and higher rates of invasive ventilation support needed (P = 0.012). TPE is a treatment method which can be safely provided in healthcare facilities with necessary medical and technical requirements. Although it is riskier to provide such treatment to critically ill children, complications can be minimized in experienced healthcare facilities. Overall results are good and can vary depending on indication.
Keywords: acute disseminated encephalomyelitis; multiorgan dysfunction syndrome; pediatric intensive care; sepsis; therapeutic plasma exchange; thrombotic microangiopathy.
© 2020 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.
Similar articles
-
Therapeutic Plasma Exchange in Critically Ill Children Requiring Intensive Care.Pediatr Crit Care Med. 2018 Feb;19(2):e97-e104. doi: 10.1097/PCC.0000000000001400. Pediatr Crit Care Med. 2018. PMID: 29401139
-
Therapeutic plasma exchange in critically ill children: A single center experience.Ther Apher Dial. 2024 Oct;28(5):793-801. doi: 10.1111/1744-9987.14141. Epub 2024 May 15. Ther Apher Dial. 2024. PMID: 38747186
-
Evaluation of patients undergoing therapeutic plasma exchange in the pediatric intensive care unit and determining the factors affecting prognosis.Ther Apher Dial. 2025 Apr;29(2):303-311. doi: 10.1111/1744-9987.14220. Epub 2024 Oct 18. Ther Apher Dial. 2025. PMID: 39425249
-
Outcomes of previously healthy pediatric patients with fulminant sepsis-induced multisystem organ failure receiving therapeutic plasma exchange.J Clin Apher. 2011;26(4):208-13. doi: 10.1002/jca.20296. Epub 2011 Jul 22. J Clin Apher. 2011. PMID: 21786317 Review.
-
Therapeutic Plasma Exchange in Tandem With Other Types of Extracorporeal Circuits: The Experience of a Pediatric Center and a Review of Other Pediatric Center Reports.J Clin Apher. 2025 Feb;40(1):e70007. doi: 10.1002/jca.70007. J Clin Apher. 2025. PMID: 39963067 Review.
Cited by
-
Role of therapeutic apheresis in the treatment of pediatric kidney diseases.Pediatr Nephrol. 2022 Feb;37(2):315-328. doi: 10.1007/s00467-021-05093-w. Epub 2021 May 15. Pediatr Nephrol. 2022. PMID: 33991255
-
Therapeutic apheresis: is it safe in children with kidney disease?Pediatr Nephrol. 2024 Aug;39(8):2451-2457. doi: 10.1007/s00467-024-06346-0. Epub 2024 Mar 19. Pediatr Nephrol. 2024. PMID: 38502222 Free PMC article.
-
[Therapeutic plasma exchange in the pediatric intensive care unit: a single-center retrospective study].Zhongguo Dang Dai Er Ke Za Zhi. 2022 Oct 15;24(10):1149-1153. doi: 10.7499/j.issn.1008-8830.2204172. Zhongguo Dang Dai Er Ke Za Zhi. 2022. PMID: 36305117 Free PMC article. Chinese.
-
Safety of Therapeutic Apheresis in Children and Adolescents.Front Pediatr. 2022 Apr 12;10:850819. doi: 10.3389/fped.2022.850819. eCollection 2022. Front Pediatr. 2022. PMID: 35498796 Free PMC article.
-
Therapeutic plasma exchange in the intensive care unit and with the critically ill, a focus on clinical nursing considerations.J Clin Apher. 2022 Aug;37(4):397-404. doi: 10.1002/jca.21984. Epub 2022 Apr 6. J Clin Apher. 2022. PMID: 35385601 Free PMC article.
References
REFERENCES
-
- Cortina G, Ojinaga V, Giner T, et al. Therapeutic plasma exchange in children: One center's experience. J Clin Apher. 2017;32:494-500.
-
- Cortina G, McRae R, Chiletti R, Butt W. Therapeutic plasma exchange in critically ill children requiring intensive care. Pediatr Crit Care Med. 2018;19:97-104.
-
- Nguyen TC, Kiss JE, Goldmann JR, Carcillo JA. The role of plasmapheresis in critical illness. Crit Care Clin. 2012;28:453-468.
-
- Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing Committee of the American Society for apheresis: The eighth special issue. J Clin Apher. 2019;34:171-354.
-
- Tekgunduz SA, Kara A, Bozkaya IO, Caglı A, Ozbek NY. Therapeutic plasma exchange in non-hematooncological disorders in pediatrics: A single center experience. Transfus Apher Sci. 2018;57:20-22.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources